NCT05972928 is a Phase 2, PHASE3 clinical trial of Sitagliptin 100mg in Polycystic Ovary Syndrome, sponsored by Beni-Suef University.

Who is sponsoring NCT05972928?

NCT05972928 is sponsored by Beni-Suef University.

What drugs are being tested in NCT05972928?

Interventions in NCT05972928: Sitagliptin 100mg.

What condition does NCT05972928 study?

NCT05972928 studies Polycystic Ovary Syndrome.

Is NCT05972928 still recruiting?

NCT05972928 is currently status unknown. Last updated 2 August 2023.

Last reviewed 2023-08-02 · How we verify

NCT05972928

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

Status unknown Phase 2, PHASE3 Last updated 2 August 2023

What this trial tests

Phase 2, PHASE3 trial testing Sitagliptin 100mg in Polycystic Ovary Syndrome in 80 participants. Status unknown.

Timeline

30 July 2023

Primary endpoint
30 October 2023

30 October 2023

Quick facts

Lead sponsor	Beni-Suef University
Phase	Phase 2, PHASE3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	30 July 2023
Primary completion	30 October 2023
Estimated completion	30 October 2023
Sites	1 location across Egypt

Drugs / interventions tested

Sitagliptin 100mg — full drug profile →

Conditions studied

Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →

Sponsor

Beni-Suef University

Who can join

Adults 20 to 40, female only, with Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Study aims to determine the proposed positive influence of Sitagliptin in manipulating hormonal , metabolic and inflammatory parameters in the treatment of Polycystic ovary syndrome and subsequent infertility

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sitagliptin 100mg

Trials testing the same drug.

NCT06329882 — Doxycycline in Type II Diabetes · Phase 1, PHASE2 · recruiting
NCT06187285 — Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia · NA · completed
NCT05579119 — SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H) · Phase 4 · completed
NCT05042505 — Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus · NA · completed
NCT04448587 — Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease · Phase 2 · unknown

Other recruiting trials for Polycystic Ovary Syndrome

Currently open trials in the same condition.

NCT07591246 — Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction · NA · recruiting
NCT07446985 — Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma? · NA · recruiting
NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07289399 — Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? · NA · recruiting

Other Beni-Suef University trials

Trials by the same sponsor.

NCT07536347 — Effect of Adding PNF to IMT on Weaning Off MV · NA · not yet recruiting
NCT07494240 — Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopi · NA · not yet recruiting
NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
NCT07482631 — Robotic Glove Training on Hand Function in Unilateral Cerebral Palsy · NA · not yet recruiting
NCT07509736 — Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05972928 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beni-Suef University
Last refreshed: 2 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05972928.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing